We are live on ! Find out more
AI

Axiom Investors Portfolio holdings

AUM $8.99B
1-Year Est. Return 44.68%
This Fund
S&P 500
This Quarter Est. Return
+5.71%
1 Year Est. Return
+44.68%
3 Year Est. Return
+214.21%
5 Year Est. Return
+302.8%
10 Year Est. Return
+1,834.44%
AUM
$11.4B
AUM Growth
-$85.4M
Cap. Flow
-$551M
Cap. Flow %
-4.84%
Top 10 Hldgs %
57.43%
Holding
147
New
19
Increased
47
Reduced
60
Closed
20

Sector Composition

Rank Sector Weight
1 Technology 35.68%
2 Communication Services 16.62%
3 Consumer Discretionary 15.11%
4 Financials 10.26%
5 Industrials 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INSM icon
101
Insmed
INSM
$29.2B
$6.37M 0.06%
87,214
-38,384
-31% -$2.83M
VXUS icon
102
Vanguard Total International Stock ETF
VXUS
$162B
$5.99M 0.05%
+92,600
New +$5.73M
CCEP icon
103
Coca-Cola Europacific Partners
CCEP
$46.9B
$5.79M 0.05%
+73,584
New +$5.64M
ACVA icon
104
ACV Auctions
ACVA
$1.24B
$5.57M 0.05%
273,970
+15,040
+6% +$277K
SPOT icon
105
Spotify
SPOT
$106B
$5.07M 0.04%
+13,748
New +$4.57M
TJX icon
106
TJX Companies
TJX
$177B
$4.87M 0.04%
+41,445
New +$4.75M
ITCI
107
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$4.59M 0.04%
62,700
-5,721
-8% -$430K
CDRE icon
108
Cadre Holdings
CDRE
$1.41B
$4.56M 0.04%
120,183
+6,828
+6% +$244K
OPCH icon
109
Option Care Health
OPCH
$3.67B
$4.52M 0.04%
144,295
-33,720
-19% -$1.03M
BPMC
110
DELISTED
Blueprint Medicines
BPMC
$4.24M 0.04%
45,824
-4,076
-8% -$405K
NICE icon
111
Nice
NICE
$5.98B
$4.04M 0.04%
23,254
-32,677
-58% -$5.61M
RGEN icon
112
Repligen
RGEN
$9.17B
$3.6M 0.03%
24,215
-16,679
-41% -$2.39M
GGAL icon
113
Galicia Financial Group
GGAL
$7.36B
$3.51M 0.03%
+83,390
New +$2.9M
UTHR icon
114
United Therapeutics
UTHR
$22.7B
$3.29M 0.03%
9,187
-4,595
-33% -$1.55M
SNDX icon
115
Syndax Pharmaceuticals
SNDX
$1.82B
$2.23M 0.02%
115,642
+20,502
+22% +$424K
RDY icon
116
Dr. Reddy's Laboratories
RDY
$10.1B
$1.84M 0.02%
+115,600
New +$1.86M
VNM icon
117
VanEck Vietnam ETF
VNM
$510M
$1.67M 0.01%
+130,700
New +$1.61M
INFY icon
118
Infosys
INFY
$51B
$1.6M 0.01%
+71,800
New +$1.57M
SUPN icon
119
Supernus Pharmaceuticals
SUPN
$2.72B
$1.57M 0.01%
50,335
-4,525
-8% -$141K
GERN icon
120
Geron
GERN
$956M
$1.47M 0.01%
322,745
-29,105
-8% -$132K
KSA icon
121
iShares MSCI Saudi Arabia ETF
KSA
$624M
$1.32M 0.01%
30,800
-34,250
-53% -$1.43M
IVV icon
122
iShares Core S&P 500 ETF
IVV
$905B
$1.24M 0.01%
2,147
-1,653
-44% -$919K
BRBR icon
123
BellRing Brands
BRBR
$1.32B
$553K ﹤0.01%
+9,100
New +$505K
CPT icon
124
Camden Property Trust
CPT
$11B
$448K ﹤0.01%
+3,630
New +$429K
ROL icon
125
Rollins
ROL
$17.9B
$310K ﹤0.01%
6,120
+1,100
+22% +$54.3K

Similar funds

Axiom Investors's Q3 2024 Portfolio in Review

As of Q3 2024, Axiom Investors held 147 positions worth $11.4B, down 0.74% from $11.5B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Axiom Investors withdrew a net $551M in Q3 2024, closing 20 positions and reducing 60 holdings. Its most notable exit was e.l.f. Beauty, an estimated $72.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 40% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Axiom Investors opened a new position in Boston Scientific worth $102M.

  • Axiom Investors's largest Q3 2024 buy was Boston Scientific: 1,217,423 shares worth $102M.
  • Axiom Investors added most to Chipotle Mexican Grill in Q3 2024, an estimated $122M increase.
  • Axiom Investors's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $261M.
  • Axiom Investors fully exited e.l.f. Beauty in Q3 2024, selling an estimated $72.1M.
  • Axiom Investors's ten largest holdings make up 57% of its $11.4B portfolio in Q3 2024.
  • Axiom Investors opened 19 new positions and closed 20 in Q3 2024.
  • Axiom Investors's portfolio value fell 0.74% quarter-over-quarter to $11.4B.

Based on Axiom Investors's 13F filing for Q3 2024, filed 12 Nov 2024.